Skip to main content

Advertisement

SpringerLink
Log in

Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer

  • Original Article - Cancer Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Genetic polymorphisms in genes involved in the immune response are already known to affect the anti-tumor immune response. This study systematically investigated the association of 14 functional SNPs in a panel of 7 genes (CCL2, CCR2, NT5E, IDO1, LAG3, PDL1, and PDCD1) involved in immune response checkpoints with the survival outcomes of Korean patients with colorectal cancer (CRC).

Methods

The genomic DNA from 668 patients with curatively resected CRC was analyzed using a Sequenom MassARRAY, along with the association with recurrence-free survival (RFS) and overall survival (OS).

Results

Among the 14 SNPs, CCL2 rs4586 and PDCD1 rs10204525 were found to have an influence on the survival outcomes of the patients with resectable CRC. CCL2 rs4586 showed a significant correlation with OS in a recessive model in a univariate analysis, as well as a multivariate analysis. In addition, PDCD1 rs10204525 revealed a significant association with RFS and OS in a recessive model in a univariate analysis and exhibited a significant impact in a multivariate analysis.

Conclusion

In conclusion, this results suggest that the genetic predisposition of the host may affect the anti-tumor immune reaction in CRC. The results of this study may also be helpful when selecting targets for novel drug development to promote the anti-tumor immune response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Adams S, Gray RJ, Demaria S et al (2014) Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol 32(27):2959–2966

    Article  PubMed  PubMed Central  Google Scholar 

  • Butt AQ, Mills KH (2014) Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines. Oncogene 33(38):4623–4631

    Article  CAS  PubMed  Google Scholar 

  • Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. Circ Res 95(9):858–866

    Article  CAS  PubMed  Google Scholar 

  • Chen L (2004) Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 4(5):336–347

    Article  CAS  PubMed  Google Scholar 

  • DeNardo DG, Brennan DJ, Rexhepaj E et al (2011) Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 1(1):54–67

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960–1964

    Article  CAS  PubMed  Google Scholar 

  • Galon J, Fridman WH, Pages F (2007) The adaptive immunologic microenvironment in colorectal cancer: a novel perspective. Cancer Res 67(5):1883–1886

    Article  CAS  PubMed  Google Scholar 

  • Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS (2014) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat 46(2):109–123

    Article  PubMed  PubMed Central  Google Scholar 

  • Ku G, Tan IB, Yau T et al (2012) Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012. Lancet Oncol 13(11):e470–e481

    Article  PubMed  Google Scholar 

  • Lee HE, Chae SW, Lee YJ et al (2008) Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer 99(10):1704–1711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mok S, Koya RC, Tsui C et al (2014) Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy. Cancer Res 74(1):153–161

    Article  CAS  PubMed  Google Scholar 

  • Mok S, Tsoi J, Koya RC et al (2015) Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition. BMC Cancer 15(1):356

    Article  PubMed  PubMed Central  Google Scholar 

  • Petersen RP, Campa MJ, Sperlazza J et al (2006) Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107(12):2866–2872

    Article  PubMed  Google Scholar 

  • Pyonteck SM, Akkari L, Schuhmacher AJ et al (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19(10):1264–1272

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Qian BZ, Li J, Zhang H et al (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475(7355):222–225

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423–1437

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331(6024):1565–1570

    Article  CAS  PubMed  Google Scholar 

  • Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29

    Article  PubMed  Google Scholar 

  • Sunakawa Y, Stremitzer S, Cao S et al (2015) Association of variants in genes encoding for macrophage-related functions with clinical outcome in patients with locoregional gastric cancer. Ann Oncol 26(2):332–339

    Article  CAS  PubMed  Google Scholar 

  • Suzuki H, Chikazawa N, Tasaka T et al (2010) Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunol Immunother 59(5):653–661

    Article  CAS  PubMed  Google Scholar 

  • Zhang G, Liu Z, Duan S et al (2010) Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection. Hum Immunol 71(12):1209–1213

    Article  CAS  PubMed  Google Scholar 

  • Zhang G, Li N, Li Z et al (2015) microRNA-4717 differentially interacts with its polymorphic target in the PD1 3′ untranslated region: a mechanism for regulating PD-1 expression and function in HBV-associated liver diseases. Oncotarget 6(22):18933–18944

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A111345). This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1420040).

Author information

Authors and Affiliations

  1. Department of Oncology/Hematology, Cancer Research Institute, Kyungpook National University, 807 Hoguk-ro, Buk-gu, Daegu, 702-210, Republic of Korea

    Shinkyo Yoon, Byung Woog Kang & Jong Gwang Kim

  2. Department of Surgery, Kyungpook National University School of Medicine, 807 Hoguk-ro, Buk-gu, Daegu, 702-210, Republic of Korea

    Su Yeon Park, Hye Jin Kim, Jun Seok Park & Gyu Seog Choi

Authors
  1. Shinkyo Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Byung Woog Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Su Yeon Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hye Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jun Seok Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gyu Seog Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jong Gwang Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jong Gwang Kim.

Ethics declarations

Conflict of interest

Authors declare that there is no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 31 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yoon, S., Kang, B.W., Park, S.Y. et al. Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer. J Cancer Res Clin Oncol 142, 1775–1780 (2016). https://doi.org/10.1007/s00432-016-2196-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-016-2196-2

Keywords

Search

Navigation